Health Plan Week
Today’s issue is brought to you by AIS's Health Plan Week, the industry's leading source of objective business, financial and regulatory news of the health insurance industry. Sign up for a $91 two-month trial subscription today.

December 9, 2016

Today's Featured Story

Trend for Provider-Led Plans Is Being Fed by Economics of Reimbursement Models
Reprinted from Health Plan Week

Despite the probability that one of the stimulants for more providers forming health plans — the Affordable Care Act public exchanges — faces gradual extinction under the Trump administration, market consultants expect the trend to continue regardless. That is because other sources of provider interest in the insurance business are likely to remain, including the bipartisan-supported Medicare Access and CHIP Reauthorization Act and the popular Medicare Advantage program.... Read Full Story

 

Quote of the Day

“There will be a multiyear transition into the replacement [for the Affordable Care Act]. This is a failed piece of legislation, and it is coming apart at the seams, but it is going to take us a while to make that transition from the repeal to actually replacing it.”

— Senate Majority Whip John Cornyn (R-Texas) told The Washington Post for a Dec. 1 story on Republican plans to replace Obamacare.

 

Today's Datapoint

$57 billion ... was spent on pharmaceuticals in 2015 by Medicaid, with the top two costliest Medicare Part D drugs (the hepatitis C treatment Harvoni and the diabetes drug Lantus) also in the top five for Medicaid spending, with both in excess of $1 billion.

From MEDICARE ADVANTAGE NEWS

 

Today from Washington

People on the Move

Rebiotix Inc. named Ken F. Blount, Ph.D., head of external research. He most recently was an associate research scientist/scholar and translational research coordinator at Yale Cancer Center and Smilow Cancer Hospital at Yale New Haven....USANA Health Sciences, Inc. said Co-CEO Dave Wentz is retiring from the company. He will be succeeded by the other co-CEO, Kevin Guest, whom the board of directors named CEO. USANA will no longer use a co-CEO management structure....Collagen Matrix, Inc. appointed Oystein Valberg chief financial officer. Most recently, he served as CFO and vice president of finance, strategy and business development for Medtronic's Surgical Technology business unit.

 

The Featured Story of the day may be accessed on the day it is transmitted without logging in to AISHealth.com. Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on AISHealth.com, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Content questions or suggestions should be directed to Executive Editor Jill Brown at jbrown@aishealth.com. If you are interested in advertising in AIS's HEALTH BUSINESS DAILY, please contact BJ Taylor at bjtaylor@aishealth.com.

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at http://www.magnetmail.net/actions/ atlantic_subscription.cfm

Copyright © 2016 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to rbiehl@aishealth.com.


Visit www.AISHealth.com
With archives of AIS's Health Business Daily, features like the News Archives, AIS Blogs and more! (Free registration required)


AISHealth  Follow AISHealth on Twitter  Follow AISHealth on Facebook  Follow AISHealth on LinkedIn